NCT07754890
- Conditions
- Cutaneous T-cell Lymphoma (CTCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
Clinical trial condition
Cutaneous T-cell Lymphoma (CTCL)
Explore clinical trials studying Cutaneous T-cell Lymphoma (CTCL). Study availability and eligibility vary by location and protocol.
9 public trials
2 recruiting studies
Cutaneous T-cell Lymphoma (CTCL) trial results
Recruiting
A Clinical Study of CHT101 in CD70-Positive Relapsed or Refractory Hematological Malignancies
NCT06914037
- Conditions
- Cutaneous T-cell Lymphoma (CTCL), Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Tianjin Medical University Cancer Institute & Hospital Tianjin, Tianjin Municipality, China
Active, not recruiting
A Phase IIa Clinical Study of Purinostat Mesylate for Injection in Patients With Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma
NCT06485219
- Conditions
- Cutaneous T-cell Lymphoma (CTCL), Disease Attributes, Hemic and Lymphatic Diseases, +15 more
- Locations
-
- Ruijin Hospital, Shanghai Jiaotong University School Of Medicine Shanghai, Shanghai Municipality, China
- West China Hospital Sichuan University Chengdu, Sichuan, China
Active, not recruiting
A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies
NCT04072458
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +40 more
- Locations
-
- Georgia Cancer Center Augusta, Georgia, United States
- New York Medical College / Westchester Medical Center Valhalla, New York, United States
- Sarah Cannon Research Institute/Tennesee Oncology Nashville, Tennessee, United States
- University of Texas Southwestern Medical Center Dallas, Texas, United States
NCT02616965
- Conditions
- Cutaneous T-cell Lymphoma (CTCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- University of Pennsylvania, Perelman Center Philadelphia, Pennsylvania, United States
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
NCT05225584
- Conditions
- Cutaneous T-cell Lymphoma (CTCL), Hematologic Diseases, Hemic and Lymphatic Diseases, +22 more
- Locations
-
- UC Irvine Health-Chao Family Comprehensive Cancer Center Orange, California, United States
- Norton Cancer Institute Louisville, Kentucky, United States
- Henry Ford Hospital Detroit, Michigan, United States
- Hackensack University Medical Center, John Theurer Cancer Center Hackensack, New Jersey, United States
NCT02580552
- Conditions
- Adult T-Cell Leukemia/Lymphoma (ATLL), Chronic Disease, Chronic Lymphocytic Leukemia (CLL), +29 more
- Locations
-
- City of Hope Duarte, California, United States
- UCSD Moores Cancer Center La Jolla, California, United States
- UCLA Department of Medicine Los Angeles, California, United States
- Chao Family Comprehensive Cancer Center at University of California, Irvine Orange, California, United States
Completed
Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides With Variable CD30 Expression Level
NCT01396070
- Conditions
- Cutaneous Lymphoma, Cutaneous T-cell Lymphoma (CTCL), Hemic and Lymphatic Diseases, +13 more
- Locations
-
- Stanford University School of Medicine Stanford, California, United States
Completed
A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL)
NCT00611208
- Conditions
- Cutaneous T-cell Lymphoma (CTCL), Hematologic Diseases, Hemic and Lymphatic Diseases, +17 more
- Locations
-
- Yale University School Of Medicine Recruiting New Haven, Connecticut, United States
- James Graham Brown Cancer Center Louisville, Kentucky, United States
- University of Texas Southwestern Medical Center Dallas, Texas, United States
- University of Texas MD Anderson Cancer Center Houston, Texas, United States